Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
about
Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertensionEvolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementNeuroprotection after stroke by targeting NOX4 as a source of oxidative stressPost-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegenerationAging-related alterations in eNOS and nNOS responsiveness and smooth muscle reactivity of murine basilar arteries are modulated by apocynin and phosphorylation of myosin phosphatase targeting subunit-1NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.Reactive oxygen species are involved in regulating alpha1-adrenoceptor-activated vascular smooth muscle contraction.Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.Endothelin-1-induced activation of rat renal pelvic contractions depends on cyclooxygenase-1 and Rho kinase.Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction.Reactive oxygen species cause endothelial dysfunction in chronic flow overload.Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction.NADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice.NOX1, 2, 4, 5: counting out oxidative stress.Differential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles.Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870).The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.The 1027th target candidate in stroke: Will NADPH oxidase hold up?Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability.NADPH oxidase has a directional response to shear stress.Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.Dietary sodium modulates the interaction between efferent renal sympathetic nerve activity and afferent renal nerve activity: role of endothelin.Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.Diabetes and Kidney Disease: Role of Oxidative Stress.NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets.Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models.Potential benefits of rho-kinase inhibition in arterial hypertension.Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.Are reactive oxygen species still the basis for diabetic complications?Superoxide modulates myogenic contractions of mouse afferent arteriolesHigh-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ.ASIC-like currents in freshly isolated cerebral artery smooth muscle cells are inhibited by endogenous oxidase activity.Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4.Antioxidants reverse age-related collateral growth impairment.Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.Ibuprofen protects ventilator-induced lung injury by downregulating Rho-kinase activity in rats.Selective inhibition of NADPH oxidase reverses the over contraction of diabetic rat aorta.Up-regulation of thromboxane A₂ impairs cerebrovascular eNOS function in aging atherosclerotic mice
P2860
Q26823318-72E0E5C2-F55F-41C9-9992-62EB8ABA288DQ26861119-D60E4094-3D06-4DD4-BBAD-43A50D3EFAE7Q26862779-428BE9FC-FECF-4B00-B847-78A72D65186BQ27323209-65298C77-7CEE-4386-87AC-AD477F200F83Q29248732-519912E8-2D6B-4955-BE14-6087C650E257Q30436865-6818EF74-EA12-4395-977C-B886BACCEE33Q34097787-2D6BB044-9E15-4D0C-BD07-024DFA810266Q34269250-5F6DF4B0-07BA-4E1D-AE83-3DE0B39C77D1Q34429159-932D799B-020E-4C47-AEFF-440064C98C36Q34433358-8283A741-8D57-4078-828A-1F92A6E2FD14Q34598465-45C42546-F20A-4FA2-81B7-2FB09E8748C4Q35114722-0C79AF6D-96B1-4DBA-8534-BC46C5CADF29Q35122894-1DF570BD-C104-4D83-973D-7054196FFC01Q35375986-1E10AFDA-59D9-4C4B-B3CC-AAF103C149C9Q35638918-E380B05F-FF4D-4853-AC4E-4F4E7C3BFCCAQ35850312-0F9E5192-3017-44A8-AB55-6E179F8699E5Q35966951-A0EF9F7F-363A-450C-B16C-B24E7DDE67EAQ36060782-543A51BC-B447-43F2-B2D1-926D9803A543Q36112519-7D11F053-698B-4007-A8FF-DD1AB2C7CAD8Q36759153-2F4A3DD4-65CC-4FA1-8DD4-BC3ED7BEA76AQ37088271-8F45A8C5-6DB6-4322-AF82-81367365CD41Q37230721-75D78A35-B013-403E-B4F5-CFC2C421C331Q37298451-0B214A57-AC80-4449-93DD-BA407DC595EAQ37337305-292EBB71-6E8B-40A4-8CA4-CAE1AA361E62Q37349206-ECFCC4F2-D41F-4D0B-90A9-B2A1E6DC231CQ37406398-A47AF350-AC56-41E1-B4F6-890801A1360EQ37460376-D59F8D57-FC01-45C4-890E-BE00FF53FF5CQ38121505-E63C1D17-8D99-4D07-A526-D6E987216B73Q38188467-1BF16C87-2A35-43F6-B8FC-93828EEE4AEFQ38451253-3189A22D-739B-44A9-9F7A-997CC8FCFD2FQ38671663-6353E528-CBA5-4174-9118-926C01099129Q38905577-47C819CA-8052-4A24-BE8B-42721E5A3E12Q39271296-CE5AC23E-F72B-4BC6-A332-6D4BFB453062Q39306347-053736AD-B668-476B-B559-5005C24F9CD0Q40055510-D157D90C-4DB4-4FB7-8F27-9478FF866DA4Q40895409-416AA18A-BF89-4D93-9C2B-1CCD990A5A0FQ41005267-49E33FE0-B776-4696-AB6F-4C266C0F5381Q41474435-056B67AE-554A-4089-A5FE-DD1C1CFE59C3Q41742525-5BED34BE-DA97-4757-819A-DAC23B087AFDQ41886253-9A815D61-FCCA-4E58-86BA-02504000F99B
P2860
Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Apocynin-induced vasodilation ...... not NADPH oxidase inhibition.
@en
Apocynin-induced vasodilation ...... not NADPH oxidase inhibition.
@nl
type
label
Apocynin-induced vasodilation ...... not NADPH oxidase inhibition.
@en
Apocynin-induced vasodilation ...... not NADPH oxidase inhibition.
@nl
prefLabel
Apocynin-induced vasodilation ...... not NADPH oxidase inhibition.
@en
Apocynin-induced vasodilation ...... not NADPH oxidase inhibition.
@nl
P2093
P2860
P356
P1476
Apocynin-induced vasodilation ...... not NADPH oxidase inhibition.
@en
P2093
Anja Steffen
Antje C Steinbach
Olaf Grisk
Rainer Rettig
Torsten Schlüter
P2860
P304
P356
10.1093/CVR/CVN185
P577
2008-07-02T00:00:00Z